More than 9,000 attendees from across the globe, including industry leaders, emerging fast-growth companies, technology creators, and investors, are expected.
ChristianaCare’s Gene Editing Institute, located in Newark, Delaware, recently announced an innovation that could accelerate CRISPR gene editing work.
The Greater Philadelphia region’s health care and life sciences community has much to celebrate as 2019 concludes.
Rapid growth and a flurry of achievements have been the hallmarks of the region’s cell & gene therapy, gene editing, and connected health companies.
Investor enthusiasm for the cell and gene therapy space is robust and growing at a breathtaking pace. From R&D through M&A, the deal data – spanning only the most recent three years – is compelling. Figures below, prepared by partner DealForma, illustrate the national trends.
Upfront payments for R&D partnerships in cell & gene therapy doubled from $15 million in 2017 to $30 million in 2018, and grew another 37% to $41 million in 2019.
The total value of […]
As 2019 draws to a close it’s fitting that we take note of the incredible momentum that could be felt across the Greater Philadelphia region’s health care and life sciences community this year, which was also the first year of the Cell & Gene Therapy and Connected Health Initiative.
Several partners in the Cell & Gene Therapy and Connected Health Initiative participated in the HLTH Conference, held October 27-30, in Las Vegas. The event attracted 6,000 senior leaders from across the healthcare ecosystem.
As 2019 draws to a close, three particularly noteworthy business acquisitions illustrate the Greater Philadelphia region’s capacity for leadership and innovation in connected health.
Leaders from Select Greater Philadelphia and Cozen O'Conner presented at CPhI Worldwide in Frankfurt, Germany, on November 5, 2019 for 45 minutes to an overflowing World of Pharma Podium audience about US regulatory issues and market trends.
For the first time, Greater Philadelphia is recognized as an emerging New World City in JLL’s Global Cities Report for leading the way in innovation in healthcare and life sciences.
